Research program title
Nanomedicinal Chemistry – A Targeted Approach to Antiviral Drug Delivery
The instances of Hepatitis C have dramatically increased on a global scale, particularly since its identification in 1989. On a national level, as of 2011, nearly 250,000 Canadians were diagnosed with this type of viral infection. These numbers continue to grow even though advances in modern medicine have brought forth cures that can be administered over a 2 to 3-month therapeutic window. However, despite the advances such therapies may deliver, a major concern is the emergence of drug-resistant variants of the virus. As such, there exists a need to develop novel nanomedicinal therapeutic paradigms that can target viral infections resulting in: (i) highly specific and tailored drug delivery, (ii) a higher degree of efficacy and (iii) lower therapeutic dosage requirements, which will reduce the nefarious side effects often experienced with conventional passive administration routes.
The proposed research program seeks to develop novel nanoparticle constructs that can selectively target viruses and deliver an antiviral therapeutic agent. The proposed program is highly multidisciplinary and will require an exceptional postdoctoral candidate to ensure its success.
Academic qualifications required
- PhD in Chemistry or related fields with relevant experience in two or more relevant areas including: organic chemistry, materials science, nanomaterials, spectroscopy among others